Free Trial

This company has been marked as potentially delisted and may not be actively trading.

OTCMKTS:BLUSF

BELLUS Health (BLUSF) Stock Price, News & Analysis

BELLUS Health logo

About BELLUS Health Stock (OTCMKTS:BLUSF)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$6.46
$14.51
52-Week Range
N/A
Volume
3.45 million shs
Average Volume
39,610 shs
Market Capitalization
$2.35 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Receive BLUSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLUSF Stock News Headlines

Trying The Natural Blush Trick
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape.
See More Headlines

BLUSF Stock Analysis - Frequently Asked Questions

BELLUS Health Inc (OTCMKTS:BLUSF) released its earnings results on Wednesday, May, 8th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by $0.01. The business earned $0.01 million during the quarter. BELLUS Health had a negative net margin of 49,910.34% and a negative trailing twelve-month return on equity of 48.37%.

Company Calendar

Last Earnings
5/08/2019
Today
6/12/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BLUSF
CIK
N/A
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.01 million
Net Margins
-49,910.34%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$30 thousand
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.35 billion
Optionable
Not Optionable
Beta
1.55

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:BLUSF) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners